LORI GERDING: Open Payments
NPI 1801834726 · MONCKS CORNER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,440 in 68 payments from 8 companies in 2025. Trend: 2023 $485 · 2024 $1,091 · 2025 $1,440
Food & beverage: $1,440
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 11 | $347 |
| Neurocrine BioSciences, Inc. | 15 | $333 |
| Janssen Pharmaceuticals, Inc | 10 | $225 |
| Alkermes, Inc. | 10 | $165 |
| Teva Pharmaceuticals USA, Inc. | 9 | $140 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $103 |
| Otsuka America Pharmaceutical, Inc. | 6 | $91 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
Products named: Qelbree, INGREZZA, INVEGA SUSTENNA, ARISTADA, CAPLYTA, UZEDY, AUSTEDO XR, COBENFY.
Industry payments across SC — which companies pay providers there.
